Quantcast

Latest Heavy metal Stories

2014-10-13 23:08:33

On October 8, the FDA announced that SAM Junctional Tourniquet Accessory (Axilla) Strap, by SAM Medical Products, is recalled due to potential clip failure. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) October 13, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on Junctional Tourniquet. The US FDA...

2014-10-09 23:11:20

Rock Band KORN Digital Game to Release Oct 8th Supported by Tour, Major Promotions and Hardcore Fan Engagement New York, NY (PRWEB) October 09, 2014 Rock Science™, The Rock Game of the Century is coming to the United States in the search for hardcore rock fans everywhere. The company has announced the official American launch of the popular mobile game which engages music fans from around the globe in a “first of its kind” pure rock trivia game. To kick off the American launch, the...

2014-10-09 08:27:08

CARLSBAD, Calif., Oct. 9, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today that it has earned an $18 million milestone payment from GlaxoSmithKline (GSK) related to the advancement of the Phase 2/3 study of ISIS-TTR(Rx) in patients with familial amyloid polyneuropathy (FAP). http://photos.prnewswire.com/prnvar/20130807/LA60006LOGO "ISIS-TTR(Rx) is the most advanced drug in our collaboration with GSK, and aside from KYNAMRO, it is also the furthest...

2014-10-02 08:28:48

CARLSBAD, Calif., Oct. 2, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announces the following webcast: What: Webcast and conference call to provide an update on the ongoing open-label Phase 2 clinical studies of ISIS-SMNRx in infants and children with spinal muscular atrophy (SMA), which will be presented on the morning (CEST) of Friday, October...

2014-10-01 08:30:41

CARLSBAD, Calif., Oct. 1, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today that it has earned a $1.5 million milestone payment from GSK related to the advancement of the program to develop ISIS-GSK4(Rx) to treat an undisclosed ocular disease. http://photos.prnewswire.com/prnvar/20130807/LA60006LOGO "Our collaboration with GSK has been very productive resulting in four drugs in development," said B. Lynne Parshall, chief operating officer at Isis. "We...

2014-09-26 20:21:49

METALLICA, LINKIN PARK, TAYLOR SWIFT, NO DOUBT, JOHN LEGEND AND DEFTONES ANNOUNCED AS INITIAL PERFORMERS FOR FIRST U.S. FESTIVAL IN LAS VEGAS MAY 8-9 AND 15-16, 2015 NEW YORK, Sept. 26, 2014 /PRNewswire/ -- Rock in Rio, the legendary music festival, has announced Metallica, Linkin Park, Taylor Swift, No Doubt, John Legend and Deftones as part of the initial lineup for its first stateside edition, Rock in Rio USA, taking place May 8-9 and May 15-16 in Las Vegas. The announcement...

2014-09-24 08:27:33

CARLSBAD, Calif., Sept. 24, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS), the leader in antisense therapeutics, today announced that management will present a company overview at the Leerink Partners Rare Disease Roundtable on Wednesday, October 1, 2014 at 8:00 a.m. ET in New York, NY. http://photos.prnewswire.com/prnvar/20130807/LA60006LOGO A live webcast of the presentation will be available on the "Investors & Media" section of the Company's website,...

2014-09-17 12:24:46

SPECIAL ANNIVERSARY CONCERT TO BE FILMED LIVE AS AN EPISODE OF AWARD-WINNING TELEVISION SHOW GUITAR CENTER SESSIONS LOS ANGELES, Sept. 17, 2014 /PRNewswire/ -- Guitar Center has announced that Grammy Award-winning rock band LINKIN PARK will be performing in Los Angeles, CA at The Wiltern on Friday, October 24(th) in celebration of the retailers 50(th) Anniversary. Fans can visit guiarcenter.com/linkinpark to enter for their chance to win a VIP trip for two to Los Angeles, CA,...

2014-09-17 08:29:10

CARLSBAD, Calif., Sept. 17, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced that it has earned a $4 million milestone payment from Achaogen, Inc. (NASDAQ: AKAO) associated with the initiation of a Phase 3 study of plazomicin in patients with serious multi-drug resistant (MDR), gram-negative bacterial infections. The Phase 3 study is designed as a superiority study to evaluate the efficacy and safety of plazomicin compared to colistin in patients with...

2014-09-10 08:39:12

Updated EXTOL Business Integrator delivers performance enhancements for integration development that reduce time to delivery and risk POTTSVILLE, Pa., Sept. 10, 2014 /PRNewswire/ -- EXTOL International, a leading provider of end-to-end business integration software and services, launched a major release of its flagship product, EXTOL Business Integrator v3.1 (EBI v3.1). With several improved integration developments, the latest version of EBI greatly reduces time to delivery and...


Latest Heavy metal Reference Libraries

Brilliant Emerald, Somatochlora metallica
2013-07-30 14:54:37

The brilliant emerald (Somatochlora metallica) is a species of dragonfly that can be found in northern areas of Eurasia. Its range includes Austria, Belgium, Croatia, Denmark, France, Germany, Norway, Serbia, Sweden, and the United Kingdom, among many other areas. This species prefers to reside near still and slow-moving water sources like rivers, canals, ponds, and moorland lakes. It is common in most areas of its range, but its total population number and population trend is unknown. It is...

More Articles (1 articles) »
Word of the Day
abrosia
  • Wasting away as a result of abstinence from food.
The word 'abrosia' comes from a Greek roots meaning 'not' and 'eating'.